Ophthalmology Innovation Summit At ASCRS 2014

Ora, Inc., the world’s leading independent, full- service ophthalmic contract research organization (CRO) and product development firm, announced today that they are the exclusive sponsor for the upcoming Ophthalmology Innovation Summit (OIS) during ASCRS 2014 in Boston, MA.

Presenting at the meeting will be two co-moderators, a prestigious group of panelists including several physicians, a representative from the FDA, and Ora executive, Aron Shapiro.

Aron Shapiro leads Ora’s business unit that supports clients as they develop products for a number of therapeutic areas including retina, glaucoma, infection, inflammation, and refractive disorders, as well as diagnostic and surgical devices. He consults for venture capital investors and strategic acquirers throughout the life cycle of ophthalmic assets. Mr. Shapiro is widely published and writes a monthly column in Retina Today.

WHEN:

April 24, 2014, 1:30PM – 2:15PM

WHERE:

Seaport Hotel, 200 Seaport Blvd, Boston, MA

WHO:

Co-moderators: Dick Lindstrom, MD, Founder & Attending Surgeon Minnesota Eye Consultants and Gil Kilman, MD, Managing Director InterWest Partners

Panelists include:

Malvina Eydelman, Director, Division of Ophthalmic Device Evaluation FDA
Aron Shapiro, Vice President Ora, Inc.
Donald Tan, MD, Medical Director Singapore National Eye Centre
Michael Mrochen, PhD, Founder & CEO IROC Science to Innovation
Roberto Zaldivar, MD, President Instituto Zaldivar S.A.
Matteo Pivovella, MD, Director Centro di Microchirurgia Ambulatoriale

TOPICS COVERED:

The Role of OUS Clinical Studies & Commercialization in Ophthalmic Innovation

Understanding the different regulatory environments for site selection and patient recruitment
INUS vs. OUS trials
FDA considerations when conducting OUS trials
When and how to work with CROs